BASF SE announced Dr. Markus Kamieth will take over as Chairman of the Board of Executive Directors, effective at the end of the Annual Shareholders’ Meeting on April 25, 2024. This decision was made by the Supervisory Board in its meeting on December 20, 2023.

Dr. Markus Kamieth.

“He combines strategic vision with operational implementation strength and will provide new impulses to the businesses and teams at BASF.” Commented Dr. Kurt Bock, Chairman of the Supervisory Board.

The Supervisory Board has appointed Anup Kothari, currently President of the Nutrition & Health division, to the Board of Executive Directors effective March 1, 2024.

Anup Kothari.

Another appointment by the Supervisory Board is Dr. Katja Scharpwinkel as the Board of Executive Directors and Industrial Relations Director, effective on February 1, 2024. She is currently President of the Europe, Middle East, Africa region.

Dr. Katja Scharpwinkel.

Katja Scharpwinkel succeeds Dr. Melanie Maas-Brunner, who informed the Supervisory Board that she will not extend her current contract which runs until January 31, 2024.

Dr. Bock stated that both Katja Scharpwinkel and Anup Kothari bring broad and relevant experience to the Board. The new team is highly qualified and has all the prerequisites to successfully shape the future development of the company.

Last but not least, the Supervisory Board has extended the contract of Michael Heinz, member of the Board of Executive Directors, until the Annual Shareholders’ Meeting in 2026.

Heinz has been a member of the Board of Executive Directors since 2011. He is responsible for the Agricultural Solutions, Nutrition & Health and Care Chemicals divisions as well as the North America and South America regions.

BASF SE announced Dr. Markus Kamieth will take over as Chairman of the Board of Executive Directors, effective at the end of the Annual Shareholders’ Meeting on April 25, 2024. This decision was made by the Supervisory Board in its meeting on December 20, 2023.

Dr. Markus Kamieth.

“He combines strategic vision with operational implementation strength and will provide new impulses to the businesses and teams at BASF.” Commented Dr. Kurt Bock, Chairman of the Supervisory Board.

The Supervisory Board has appointed Anup Kothari, currently President of the Nutrition & Health division, to the Board of Executive Directors effective March 1, 2024.

Anup Kothari.

Another appointment by the Supervisory Board is Dr. Katja Scharpwinkel as the Board of Executive Directors and Industrial Relations Director, effective on February 1, 2024. She is currently President of the Europe, Middle East, Africa region.

Dr. Katja Scharpwinkel.

Katja Scharpwinkel succeeds Dr. Melanie Maas-Brunner, who informed the Supervisory Board that she will not extend her current contract which runs until January 31, 2024.

Dr. Bock stated that both Katja Scharpwinkel and Anup Kothari bring broad and relevant experience to the Board. The new team is highly qualified and has all the prerequisites to successfully shape the future development of the company.

Last but not least, the Supervisory Board has extended the contract of Michael Heinz, member of the Board of Executive Directors, until the Annual Shareholders’ Meeting in 2026.

Heinz has been a member of the Board of Executive Directors since 2011. He is responsible for the Agricultural Solutions, Nutrition & Health and Care Chemicals divisions as well as the North America and South America regions.